2008 Clinical Trials Consumption Medicine 
Cannabis Law Report
MARCH 29, 2022
NZ’s Greenfern Industries say it is the first New Zealand medicinal cannabis company to be awarded B Corp certification. carbonzero certified medicinal cannabis and industrial hemp company. Rebuilt in 2008, Greenfern’s crowdfunding campaign in 2020 enabled the firm to buy the power station outright. So, what is a “ B Corp “?
The Cannigma
JANUARY 13, 2023
Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. For example, researchers at Hopkins Medicine point to changes in chemical compounds like CGRP , serotonin and hormones like estrogen affecting pain levels.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
Expert insights. Personalized for you.
52 
Let's personalize your content